CBDY logo

Target Group Inc. (CBDY) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CBDY, $ (piyasa değeri 0) fiyatla Healthcare işi olan Target Group Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 49/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
49/100 AI Puanı

Target Group Inc. (CBDY) Sağlık ve Boru Hattı Genel Bakışı

CEOAnthony Carlo Zarcone
Çalışanlar41
MerkezHamilton, CA
Halka Arz Yılı2015
SektörHealthcare

Target Group Inc. is a Canadian cannabis company focused on cultivating, processing, and distributing curated cannabis products for the adult-use medical and recreational markets. With a diverse product portfolio including flower, extracts, edibles, and topicals, Target Group aims to capture market share through product innovation and strategic collaborations.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Target Group Inc. presents a speculative investment opportunity within the Canadian cannabis market. The company's diverse product portfolio, including innovative offerings like infused beverages and the Wisp vaporizer system, positions it to capture a segment of the adult-use and medical cannabis markets. The collaboration agreement with cGreen, Inc. for True Focus distribution offers potential upside in addressing THC-related side effects. However, the company's negative profit margin of -11.8% and reliance on the OTC market introduce significant risks. Future profitability hinges on successful product launches, effective cost management, and favorable regulatory developments in the cannabis industry. Investors should carefully consider the high beta of 1.49, indicating significant volatility relative to the market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Gross Margin of 57.2% indicates strong pricing power and efficient production processes.
  • Collaboration agreement with cGreen, Inc. for manufacturing and distributing True Focus, a THC antidote, provides a unique market opportunity.
  • Offers Wisp, a single-use pre-measured pod and vaporizer system, catering to consumer demand for convenient cannabis consumption.
  • Operates in the Canadian adult-use medical and recreational cannabis market, a rapidly growing sector with increasing consumer acceptance.
  • Market capitalization of $0.00B reflects the company's small size and potential for high growth or significant risk.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio including flower, extracts, edibles, and topicals.
  • Strategic collaborations with cGreen, Inc. and Serious Seeds B.V.
  • Proprietary product offerings like the Wisp vaporizer system.
  • Presence in the rapidly growing Canadian cannabis market.

Zayıflıklar

  • Negative profit margin of -11.8%.
  • Reliance on the OTC market.
  • Small market capitalization of $0.00B.
  • Limited brand recognition compared to larger competitors.

Katalizörler

  • Ongoing: Expansion of product line to include new and innovative cannabis products.
  • Ongoing: Strategic partnerships and acquisitions to expand market reach.
  • Upcoming: Potential regulatory changes in the Canadian cannabis market.
  • Ongoing: Increasing consumer demand for CBD wellness products.
  • Ongoing: Development of proprietary technology for cultivation and product formulation.

Riskler

  • Ongoing: Intense competition from established cannabis companies.
  • Ongoing: Evolving regulations and changing consumer preferences.
  • Potential: Supply chain disruptions.
  • Potential: Risk of product recalls or safety concerns.
  • Ongoing: Negative profit margin and reliance on the OTC market.

Büyüme Fırsatları

  • Expansion of Product Line: Target Group has the opportunity to expand its product line to include new and innovative cannabis products, such as edibles, beverages, and topicals. The market for these products is growing rapidly, and Target Group could capitalize on this trend by developing high-quality, differentiated products. This expansion could target specific consumer segments, such as wellness-focused individuals seeking CBD products or recreational users looking for novel consumption methods. The timeline for this growth opportunity is immediate, with ongoing product development and market testing.
  • Strategic Partnerships and Acquisitions: Target Group can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. Partnering with established cannabis companies or acquiring smaller, innovative businesses could provide access to new markets, technologies, and expertise. This strategy could accelerate growth and enhance Target Group's competitive position. The timeline for this growth opportunity is medium-term, requiring careful due diligence and negotiation.
  • International Expansion: Target Group could explore opportunities to expand its operations into international markets, particularly in regions where cannabis is legal or decriminalized. This expansion could provide access to new customers and revenue streams. However, international expansion also involves significant risks, such as regulatory compliance and cultural differences. The timeline for this growth opportunity is long-term, requiring careful planning and execution.
  • Development of Proprietary Technology: Investing in the development of proprietary technology, such as advanced cultivation techniques or innovative product formulations, could provide Target Group with a competitive advantage. This technology could improve product quality, reduce costs, or create unique product offerings. The timeline for this growth opportunity is medium-term, requiring ongoing research and development efforts.
  • Focus on CBD Wellness Products: Target Group can capitalize on the growing demand for CBD wellness products by expanding its offerings in this area. CBD products are increasingly popular for their potential health benefits, and Target Group could develop a range of CBD-infused products targeting specific wellness needs. This strategy could attract a new customer base and generate significant revenue growth. The timeline for this growth opportunity is immediate, with ongoing product development and marketing efforts.

Fırsatlar

  • Expansion of product line to include new and innovative cannabis products.
  • Strategic partnerships and acquisitions to expand market reach.
  • International expansion into new markets.
  • Development of proprietary technology for cultivation and product formulation.

Tehditler

  • Intense competition from established cannabis companies.
  • Evolving regulations and changing consumer preferences.
  • Potential for supply chain disruptions.
  • Risk of product recalls or safety concerns.

Rekabet Avantajları

  • Established presence in the Canadian cannabis market.
  • Diverse product portfolio catering to various consumer preferences.
  • Strategic collaborations and licensing agreements.
  • Proprietary product offerings like the Wisp vaporizer system.

CBDY Hakkında

Target Group Inc., formerly Chess Supersite Corporation, was incorporated in 2013 and rebranded in July 2018 to focus on the burgeoning cannabis market. Based in Hamilton, Canada, the company cultivates, processes, and distributes a range of cannabis products for the adult-use medical and recreational sectors. Their product line includes cannabis flower, extract pods for vaporizers, pre-rolls, k-cup infused coffee and tea pods, infused beverages and edibles, topical products, and CBD wellness products. A key offering is the Wisp, a single-use pre-measured pod and vaporizer system designed for vaporizing natural herbs, including cannabis. Target Group has established strategic collaborations, including an agreement with cGreen, Inc. to manufacture and distribute the THC antidote True Focus in the United States, Europe, and the Caribbean. They also have a distribution, collaboration, and licensing agreement with Serious Seeds B.V., further expanding their market reach and product offerings. With 41 employees, Target Group is positioning itself to capitalize on the growing demand for diverse and innovative cannabis products in the Canadian market.

Ne Yaparlar

  • Cultivates cannabis plants for the adult-use medical and recreational markets.
  • Processes raw cannabis into various product formats.
  • Distributes cannabis products to retailers and consumers in Canada.
  • Manufactures cannabis flower and extract pods for vaporizer use.
  • Produces cannabis pre-rolls for convenient consumption.
  • Creates k-cup infused coffee and tea pods with cannabis.
  • Develops and sells infused cannabis beverages and edibles.
  • Offers infused topical products and CBD wellness products.

İş Modeli

  • Cultivation and processing of cannabis plants.
  • Manufacturing and distribution of cannabis products.
  • Revenue generation through product sales to retailers and consumers.
  • Strategic collaborations and licensing agreements to expand market reach.

Sektör Bağlamı

The Canadian cannabis market is experiencing substantial growth, driven by increasing legalization and consumer acceptance. Companies like Target Group Inc. operate in a competitive landscape that includes both large, established players and smaller, niche-focused businesses. The market is characterized by evolving regulations, product innovation, and increasing demand for diverse cannabis products. Target Group's focus on curated products and strategic collaborations positions it to capture a share of this expanding market, but it faces competition from companies such as ALID, BINP, BMMJ, CPMD, and EXMT, all vying for market share.

Kilit Müşteriler

  • Adult-use recreational cannabis consumers.
  • Medical cannabis patients with prescriptions.
  • Retailers and dispensaries selling cannabis products.
  • Consumers seeking CBD wellness products.
AI Güveni: 71% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Target Group Inc. (CBDY) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CBDY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CBDY için Wall Street fiyat hedefi analizi.

MoonshotScore

49/100

Bu puan ne anlama geliyor?

MoonshotScore, CBDY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Anthony Carlo Zarcone

CEO

Anthony Carlo Zarcone is the CEO of Target Group Inc., leading a team of 41 employees. Information regarding his detailed career history and educational background is not available in the provided data. As CEO, he is responsible for the overall strategic direction and operational management of the company, guiding its efforts in the cultivation, processing, and distribution of cannabis products in the Canadian market.

Sicil: Specific achievements and milestones under Anthony Carlo Zarcone's leadership are not detailed in the provided data. However, as CEO, he has overseen the company's focus on developing a diverse product portfolio, including innovative offerings like the Wisp vaporizer system, and establishing strategic collaborations with companies like cGreen, Inc. and Serious Seeds B.V.

CBDY OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Target Group Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity on the OTC market can be highly variable. Given that CBDY trades on the OTC Other tier, it is likely to experience low trading volume and wide bid-ask spreads. This can make it difficult for investors to buy or sell shares quickly and at a favorable price. The limited liquidity increases the risk of price volatility and potential losses.
OTC Risk Faktörleri:
  • Limited financial disclosure increases the difficulty of assessing the company's financial health.
  • Low trading volume and wide bid-ask spreads can lead to price volatility and difficulty in executing trades.
  • Higher risk of fraud or manipulation compared to companies listed on major exchanges.
  • OTC Other tier status indicates the company may not meet minimum financial standards.
  • Potential for delisting or suspension of trading due to non-compliance with OTC regulations.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and compliance with regulatory requirements.
  • Review available financial statements and assess the company's financial health.
  • Research the company's management team and their track record.
  • Understand the company's business model and competitive landscape.
  • Assess the liquidity of the stock and the potential for price volatility.
  • Consult with a financial advisor before making any investment decisions.
  • Check for any legal or regulatory issues involving the company.
Meşruiyet Sinyalleri:
  • Established presence in the Canadian cannabis market.
  • Diverse product portfolio catering to various consumer preferences.
  • Strategic collaborations with cGreen, Inc. and Serious Seeds B.V.
  • Company has been in operation since 2013.

CBDY Healthcare Hisse Senedi SSS

CBDY için değerlendirilmesi gereken temel faktörler nelerdir?

Target Group Inc. (CBDY) şu anda yapay zeka skoru 49/100, düşük puanı gösteriyor. Temel güçlü yan: Diverse product portfolio including flower, extracts, edibles, and topicals.. İzlenmesi gereken birincil risk: Ongoing: Intense competition from established cannabis companies.. Bu bir finansal tavsiye değildir.

CBDY MoonshotScore'u nedir?

CBDY şu anda MoonshotScore'da 49/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CBDY verileri ne sıklıkla güncellenir?

CBDY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CBDY hakkında ne diyor?

CBDY için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CBDY'a yatırım yapmanın riskleri nelerdir?

CBDY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition from established cannabis companies.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CBDY'ın P/E oranı nedir?

CBDY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CBDY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CBDY aşırı değerli mi, yoksa düşük değerli mi?

Target Group Inc. (CBDY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CBDY'ın temettü verimi nedir?

Target Group Inc. (CBDY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited information available on CEO's background and track record.
  • Disclosure status on OTC markets is unknown, increasing investment risk.
Veri Kaynakları

Popüler Hisseler